USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus
23 January 2026
1 min read

USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

New York, Jan 23, 2026, 14:55 EST — Regular session

  • Shares of U.S. Bancorp fell roughly 1% in afternoon trading, following a wider decline across the banking sector.
  • According to SEC filings, the lender priced $2.25 billion in fixed-to-floating senior notes this week.
  • Next week’s Federal Reserve meeting has investors focused on the future of interest rates and the implications for bank margins.

U.S. Bancorp shares slipped 1.1% to $55.58 Friday afternoon, surrendering part of this week’s gains amid a broader pullback in U.S. bank stocks.

The pullback comes as investors brace for next week’s Fed meeting and its implications for banks’ net interest income — the difference between earnings on loans and costs on deposits.

Broader U.S. equities held steady, while bank stocks stumbled. The SPDR S&P Bank ETF dropped roughly 3%, and the SPDR S&P Regional Banking ETF fell about 3% in afternoon sessions.

U.S. Bancorp revealed in SEC filings that it priced two fixed-to-floating senior note tranches: $1.25 billion maturing in 2032 with a 4.481% coupon, and $1 billion due 2037 at 5.033%. The coupons start fixed, then switch to floating rates tied to compounded SOFR, plus spreads of 86.7 and 110.1 basis points, respectively (a basis point equals 0.01 percentage point). 1

Regional banks took a hit after First Citizens BancShares forecast net interest income that missed Wall Street expectations, dragging the sector down. “Little good news from the financials today,” said Macrae Sykes, a portfolio manager at Gabelli Funds. A Truist analyst noted the “difficult adjustment to lower rates.” 2

U.S. Bancorp wrapped up Thursday at $56.18, hitting a high of $56.70 during the session. The volume reached roughly 22.47 million shares, more than twice what it’s seen so far on Friday. 3

Earlier this week, the lender posted a fourth-quarter net income attributable to U.S. Bancorp of $2.045 billion, with diluted EPS hitting $1.26. It also announced plans to acquire BTIG, aiming to close the deal in the second quarter of 2026, pending regulatory approval. CEO Gunjan Kedia highlighted “record consumer deposits” as a key driver behind the rise in net interest income and margin expansion. 4

Shares of Wells Fargo slipped 1.3%, Bank of America fell 1.5%, and JPMorgan was down roughly 2% in afternoon trading as other big banks also took a hit.

The larger risk for the group remains Washington: President Donald Trump’s proposal to cap credit card interest rates at 10%. Kedia warned analysts that such a cap would harm customers, estimating “90 plus percent” would feel the pinch. KBW’s Sanjay Sakhrani described a negotiated compromise as the only “somewhat viable option.” 5

Investors now turn their attention to the Fed’s upcoming two-day policy meeting on Jan. 27-28. All eyes will be on Chair Jerome Powell’s press conference on Jan. 28 for clues on any changes to the rate outlook that might shake bank stocks. 6

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings
Previous Story

Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings

Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom
Next Story

Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom

Go toTop